FDA Inspection 1218362 — GEV Co.,Ltd.
The FDA completed an inspection of GEV Co.,Ltd. on September 6, 2023 in Eumseong. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 6, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Eumseong (Korea (the Republic of))